期刊文献+

3种左旋多巴片剂的药物动力学及生物利用度比较 被引量:4

Comparison of pharmacokinetics and bioavailability of three kinds of levodopa tablets in healthy volunteers
下载PDF
导出
摘要 目的 :比较 3种左旋多巴片剂 (A、B和 C片 )的生物利用度和药物动力学。方法 :8名健康志愿者分别单剂量口服 2 0 0mg 3种药物 ,血药浓度由本实验室改进的高效液相色谱法测得。结果 :左旋多巴的药 -时曲线符合二室模型 ,A、B和 C片的 tmax分别为 (4 8.47± 13.86 )、(15 2 .6 5± 46 .71)和 (31.38± 7.74) min;cmax分别为 (3.17± 1.0 7)、(1.0 4± 0 .42 )和 (3.5 5± 0 .91)︼g/ml;AUC0→∞ 分别为 (4 2 4.44± 6 7.5 0 )、(2 97.36± 5 2 .18)和 (4 0 6 .0 9± 85 .0 2 ) ︼g· m l/ min。B和 C片相对于 A片的相对生物利用度分别为 (70 .17± 7.41) %和 (97.6 3± 11.94) %。结论 :B片较 A片有达峰时间长、峰浓度低的特点 ,C片与 A片相比具有吸收快、达峰时间短的特点。 AIM: To compare the pharmacokinetics and bioavailability of 3 levodopa tablets (A, B, C). METHODS: Eight healthy volunteers were given 3 preparations with a single oral dose of 200 mg in a randomized crossover study. Plasma concentrations of levodopa were measured by high performance liquid chromatography (HPLC). RESULTS: The concentration time curves of levodopa fitted to a two compartment model. The t max of the A, B and C with A were (48 47±13 86), (152 65±46 71) and (31 38±7 74) min; the c max were (3 17±1 07), (1 04±0 42) and (3 55±0 91) μg/ml; and the AUC 0→∞ were (424 44±67 50), (297 36±52 18) and (406 09±85 02) μg·ml/min, respectively. The relative bioavailabilities of B and C with A were (70 17±7 14)% and (97 63±11 94)%. CONCLUSION: These data suggest that B has characters of slow absorption and release compared with A. C was absorbed quickly than A.
出处 《中国临床药学杂志》 CAS 2000年第6期352-354,共3页 Chinese Journal of Clinical Pharmacy
关键词 左旋多巴 药物动力学 帕金森病 生物利用度 HPLC levodopa pharmacokinetics bioavailability high performance liquid chromatography
  • 相关文献

参考文献4

  • 1[1]Lees AJ. Levodopa substitution: the gold standard. Clin Neuropharmacol, 1994, 17(Suppl 3):S1
  • 2[2]Hyland K, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem, 1992, 38(12):2405
  • 3[3]Dethy S, Laute MA, Blercom NV, et al. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients. Clin Chem, 1997, 43(5):740
  • 4[4]Fornadi F, Milani F, Werner M. Modapar dispersible in the treatment of advanced parkinson's disease. Clin Neuropharmacol, 1994, 17(Suppl 3):S7

同被引文献59

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部